North America EEG Devices Market
Electroencephalography (EEG) is the study of electrical brain action along with the scalp. With the help of multiple electrodes placed on the head, the EEG equipment examines voltage fluctuations resulting from ionic current flows in the brain's neurons. EEG is among the most stable and predicative pointers when analysing human cognition, evaluating a subject's health condition, or observing their mental state. EEG is widely used to detect epilepsy. Moreover, the device is used to identify sleep disorders, coma, anaesthesia, encephalopathies, and brain death. The device is utilized for the diagnosis of tumours, stroke, and other brain ailments.
Thus, the significantly rising elderly population is expected to create a significant demand for EEG devices in the coming years, which is further anticipated to drive the EEG devices market.
Due to coronavirus spreading, many cities are shutting down, causing treatments and doctors/surgeons appointment cancellations. The patients suffering from critical surgeries such as spinal surgery, neurosurgery, and ENT surgery need physical awareness and need to implement procedures in the clinics. The procedure includes Intraoperative Neuromonitoring by systems, services, and accessories. Moreover, companies are also focused on manufacturing COVID diagnostics and related products. For instance, in June 2020, Ceribell Inc., a Mountain View, Calif.-based startup, deployed its cloud-linked, portable electroencephalogram (EEG) device to enable EEG assessments in minutes in emergency rooms and intensive care units. The Rapid Response EEG system is used in the Montefiore Health System in New York and at Northwell Health’s North Shore University Hospital, providers at the epicenter of the US COVID-19 crisis. Also, in April 2020, Fresenius Medical Care entered multiple partnerships with other dialysis providers to combat the COVID19 pandemic in the US. In North America, Fresenius Medical Care has collaborated with DaVita Inc. and other dialysis service providers to respond to COVID-19. This partnership is aimed to provide and support the broader kidney care community in the US by offering isolation capacity for dialysis patients infected by COVID-19. Therefore, COVID-19 had a negative impact on the EEG devices market.
Strategic insights for the North America EEG Devices provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 436.1 Million |
| Market Size by 2028 | US$ 733.5 Million |
| Global CAGR (2021 - 2028) | 7.7% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The geographic scope of the North America EEG Devices refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The EEG devices market in North America is expected to grow from US$ 436.1 million in 2021 to US$ 733.5 million by 2028; it is estimated to grow at a CAGR of 7.7% from 2021 to 2028. In May 2018, MemoryMD received FDA approval for a disposable 19-channel EEG headset, NeuroCap. Along with the NeuroEEG, wireless amplifier wore around the arm that transmits to computers and cloud-based databases via Bluetooth that was accepted. The company will also launch its convenient approach in EEG testing for clinicians treating patients at the point of care. Additionally, Zeto, Inc. received approval from the FDA for its dry electrode EEG headset, called zEEG. The device is developed to be used in the clinical setting. The zEEG is the first FDA approved dry electrode EEG headset with a cloud platform that provides instant upload, tools for investigation, and remote explanation by neurologists. Therefore, due to developments in the field of medical, the market for EEG devices is expected to grow soon significantly.
In terms of product, the 32-channel EEG segment accounted for the largest share of the North America EEG devices market in 2020. In terms of application, the brain tumour segment accounted for the largest share of the North America EEG devices market in 2020. In terms of device type, the standalone devices segment accounted for the largest share of the North America EEG devices market in 2020. In terms of end user, the hospitals and clinics segment held a larger market share of the EEG devices market in 2020.
A few major primary and secondary sources referred to for preparing this report on the EEG devices market in North America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report areKoninklijke Philips N.V.
By Product
By Application
By Device Type
By End User
By Country
The North America EEG Devices Market is valued at US$ 436.1 Million in 2021, it is projected to reach US$ 733.5 Million by 2028.
As per our report North America EEG Devices Market, the market size is valued at US$ 436.1 Million in 2021, projecting it to reach US$ 733.5 Million by 2028. This translates to a CAGR of approximately 7.7% during the forecast period.
The North America EEG Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America EEG Devices Market report:
The North America EEG Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America EEG Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America EEG Devices Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America EEG Devices Market
